GSK Achieves Strong Sales Growth In Q1 Despite Cost Of Living Pressures On Consumers
Executive Summary
GSK Consumer Healthcare's CEO Brian McNamara said he had not seen signs that the cost of living crisis was impacting consumer purchases, with sales at the business up 16% in Q1.
You may also be interested in...
Haleon Starts Standalone Life By Raising Sales Expectations
A better than expected first-half performance has put Haleon on a sure footing for the rest of the year following its recent demerger from GSK.
Euro Q2 Consumer Health Earnings Preview: Volatility, Delay, Upturn And Goodbye
Major Europe-based consumer health players Bayer, Sanofi, Reckitt and GSK feature in this sales and earnings preview, which highlights what to look out for as these four firms report their Q2 2022 results over the coming weeks.
Emergen-C Adds Apple Cider Vinegar And Ashwagandha To Botanical Supplement Options
Immune-supplement brand Emergen-C has expanded its botanicals line to include pandemic-popular herbal ingredients apple cider vinegar and ashwagandha.